Oxepanoprolinamides

N/A

Report date: 2025/05/09 14:04:05
NME

Base Information

Drug NameOxepanoprolinamides
Drug Alias NameOPPs
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRibosome inhibitors
TargetsNot applicable
Therapy Area/IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard UniversityKinvard Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesKinvard Bio Inc
Inactive CompaniesN/A
Active IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A